Infectious agents and xenobiotics in the etiology of primary biliary cirrhosis

Disease Markers

Volumn 29, Issue 6, 2010, Pages 287-299

  Selmi, Carlo ^a   De Santis, Maria ^a,b   Cavaciocchi, Francesca ^a,b   Gershwin, M Eric ^c  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OCTYNOIC ACID; 6 BROMOHEXANOATE ACID; B7 ANTIGEN; BETA DEFENSIN; CD40 ANTIGEN; CD86 ANTIGEN; CONNECTIVE TISSUE GROWTH FACTOR; ENDOTHELIN 1; HALOTHANE; IMMUNOGLOBULIN A; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MITOCHONDRION ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; PYRUVATE DEHYDROGENASE COMPLEX; THIOCTIC ACID; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

APOPTOSIS; ARTICLE; ASCARIDIA GALLI; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BORRELIA BURGDORFERI; CELL DEDIFFERENTIATION; DISEASE PREDISPOSITION; ENVIRONMENT; EPITHELIUM CELL; EPSTEIN BARR VIRUS; ESCHERICHIA COLI; FAMILY HISTORY; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; LACTOBACILLUS DELBRUECKII; LIFESTYLE; MEDICAL HISTORY; MYCOBACTERIUM GORDONAE; MYCOPLASMA; NEMATODE; NONHUMAN; NOVOSPHINGOBIUM AROMATICIVORANS; PARACOCCUS DENITRIFICANS; PHAGOCYTOSIS; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SALMONELLA MINNESOTA; STREPTOCOCCUS INTERMEDIUS; T LYMPHOCYTE; TH17 CELL; TRYPANOSOMA; YERSINIA ENTEROCOLITICA;

EID: 78651064276     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2010-0746     Document Type: Article

References (160)

1. M.E. Gershwin and I.R. Mackay, The causes of primary biliary cirrhosis: Convenient and inconvenient truths, Hepatology 47 (2008), 737-745. (Pubitemid 351280742)
2. M.E. Gershwin, A.A. Ansari, I.R.Mackay, Y. Nakanuma, A. Nishio, M.J. Rowley and R.L. Coppel, Primary biliary cirrhosis: An orchestrated immune response against epithelial cells, Immunol Rev 174 (2000), 210-225. (Pubitemid 30201390)
3. M.E. Gershwin, I.R. Mackay, A. Sturgess and R.L. Coppel, Identification and specificity of a cdna encoding the 70 kdmitochondrial antigen recognized in primary biliary cirrhosis, J Immunol 138 (1987), 3525-3531. (Pubitemid 17071942)
4. C. Selmi, M.J. Mayo, N. Bach, H. Ishibashi, P. Invernizzi, R.G. Gish, S.C. Gordon, H.I.Wright, B. Zweiban, M. Podda andM.E.Gershwin, Primary biliary cirrhosis inmonozygotic and dizygotic twins: Genetics, epigenetics, and environment, Gastroenterology 127 (2004), 485-492. (Pubitemid 39091897)
5. G.M. Hirschfield, X. Liu, C. Xu, Y. Lu, G. Xie, X. Gu, E.J. Walker, K. Jing, B.D. Juran, A.L. Mason, R.P. Myers, K.M. Peltekian, C.N. Ghent, C. Coltescu, E.J. Atkinson, E.J. Heathcote, K.N. Lazaridis, C.I. Amos and K.A. Siminovitch, Primary biliary cirrhosis associated with hla, il12a, and il12rb2 variants, N Engl J Med 360 (2009), 2544-2555.
6. C. Selmi, A. Lleo, S. Pasini, M. Zuin and M.E. Gershwin, Innate immunity and primary biliary cirrhosis, CurrMolMed 9 (2009), 45-51.
7. H. Ishibashi,M. Nakamura, A.Komori, K.Migita and S. Shimoda, Liver architecture, cell function, and disease, Semin Immunopathol 31 (2009), 399-409.
8. C. Selmi, M. Zuin and M.E. Gershwin, The finished business of primary biliary cirrhosis, J Hepatol 49 (2008), 451-460.
9. C. Selmi, M. Zuin, C.L. Bowlus and M.E. Gershwin, Antimitochondrial antibodynegative primary biliary cirrhosis, Clin Liver Dis 12 (2008), 173-185, ix. (Pubitemid 351163141)
10. P. Invernizzi, C. Selmi and M.E. Gershwin, Update on primary biliary cirrhosis, Dig Liver Dis 42 (2010), 401-408.
11. L.E. Holz, A. Warren, D.G. Le Couteur, D.G. Bowen and P. Bertolino, Cd8+ t cell tolerance following antigen recognition on hepatocytes, J Autoimmun 34 (2010), 15-22.
12. A. Carambia and J. Herkel, Cd4 t cells in hepatic immune tolerance, J Autoimmun 34 (2010), 23-28.
13. Y.H. Chuang, R.Y. Lan and M.E. Gershwin, The immunopathology of human biliary cell epithelium, Semin Immunopathol 31 (2009), 323-331.
14. N. Corazza, A. Badmann and C. Lauer, Immune cellmediated liver injury, Semin Immunopathol 31 (2009), 267-277.
15. J.H. Aron and C.L. Bowlus, The immunobiology of primary sclerosing cholangitis, Semin Immunopathol 31 (2009), 383-397.
16. Y. Ichiki, C.L. Bowlus, S. Shimoda, H. Ishibashi, J.M. Vierling and M.E. Gershwin, T cell immunity and graftversushost disease (gvhd), Autoimmun Rev 5 (2006), 1-9. (Pubitemid 41759436)
17. M.S. Longhi, Y. Ma, G. MieliVergani and D. Vergani. Aetiopathogenesis of autoimmune hepatitis, J Autoimmun 34 (2010), 7-14.
18. X.M. Chen, S.P. O-Hara, J.B. Nelson, P.L. Splinter, A.J. Small, P.S. Tietz, A.H. Limper and N.F. LaRusso, Multiple tlrs are expressed in human cholangiocytes and mediate host epithelial defense responses to cryptosporidium parvum via activation of nfkappab, J Immunol 175 (2005), 7447-7456. (Pubitemid 41713442)
19. X.M. Chen, S.P. O-Hara and N.F. LaRusso, The immunobiology of cholangiocytes, Immunol Cell Biol 86 (2008), 497-505.
20. G. Fava, S. Glaser, H. Francis and G. Alpini, The immunophysiology of biliary epithelium, Semin Liver Dis 25 (2005), 251-264. (Pubitemid 41254574)
21. K. Harada, K. Ohba, S. Ozaki, K. Isse, T.Hirayama, A.Wada and Y. Nakanuma, Peptide antibiotic human betadefensin1 and 2 contribute to antimicrobial defense of the intrahepatic biliary tree, Hepatology 40 (2004), 925-932. (Pubitemid 39288126)
22. C. Selmi, I.R.Mackay and M.E. Gershwin, The immunological milieu of the liver, Semin Liver Dis 27 (2007), 129-139. (Pubitemid 46871659)
23. M.P. Leon,M.F.Bassendine, P.Gibbs,M. Thick and J.A.Kirby, Immunogenicity of biliary epithelium: Study of the adhesive interaction with lymphocytes, Gastroenterology 112 (1997), 968-977. (Pubitemid 27113824)
24. G. Ballardini, R. Mirakian, F.B. Bianchi, E. Pisi, D. Doniach and G.F. Bottazzo, Aberrant expression of hladr antigens on bileduct epithelium in primary biliary cirrhosis: Relevance to pathogenesis, Lancet 2 (1984), 1009-1013. (Pubitemid 14021713)
25. J.J. Van den Oord, R. Sciot and V.J. Desmet, Expression of mhc products by normal and abnormal bile duct epithelium, J Hepatol 3 (1986), 310-317. (Pubitemid 17227479)
26. R.C. Ayres, J.M. Neuberger, J. Shaw, R. Joplin and D.H. Adams, Intercellular adhesion molecule1 and mhc antigens on human intrahepatic bile duct cells: Effect of proinflammatory cytokines, Gut 34 (1993), 1245-1249. (Pubitemid 23274549)
27. K. Tsuneyama, J. Van de Water, P.S. Leung, S. Cha, Y. Nakanuma, M. Kaplan, R. De Lellis, R. Coppel, A. Ansari and M.E. Gershwin, Abnormal expression of the e2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class ii and bb1/b7 expression, Hepatology 21 (1995), 1031-1037.
28. S. Sakisaka, K. Gondo, M. Yoshitake, M. Harada, M. Sata, K. Kobayashi and K. Tanikawa, Functional differences between hepatocytes and biliary epithelial cells in handling polymeric immunoglobulin a2 in humans, rats, and guinea pigs, Hepatology 24 (1996), 398-406. (Pubitemid 26260038)
29. N. Fukushima, G. Nalbandian, J. Van De Water, K. White, A.A. Ansari, P. Leung, T. Kenny, S.G. Kamita, B.D. Hammock, R.L. Coppel, F. Stevenson, H. Ishibashi and M.E. Gershwin, Characterization of recombinant monoclonal iga antipdce2 autoantibodies derived from patients with pbc, Hepatology 36 (2002), 1383-1392. (Pubitemid 35403529)
30. A. Tanaka, S. Nezu, S. Uegaki, M. Mikami, S. Okuyama, N. Kawamura, M. Aiso, M.E. Gershwin, S. Takahashi, C. Sel mi and H. Takikawa, The clinical significance of iga antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis, Ann N Y Acad Sci 1107 (2007), 259-270. (Pubitemid 47528803)
31. V. Barak, C. Selmi, M. Schlesinger, M. Blank, N. AgmonLevin, I. Kalickman, M.E. Gershwin and Y. Shoenfeld, Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis, J Autoimmun (2009).
32. K.A. Padgett, C. Selmi, T.P. Kenny, P.S. Leung, D.L. Balkwill, A.A. Ansari, R.L. Coppel and M.E. Gershwin, Phylogenetic and immunological definition of four lipoylated proteins from novosphingobium aromaticivorans, implications for primary biliary cirrhosis, J Autoimmun 24 (2005), 209-219. (Pubitemid 40545883)
33. P.Macdonald, J. Palmer, J.A. Kirby and D.E. Jones, Apoptosis as amechanism for cell surface expression of the autoantigen pyruvate dehydrogenase complex, Clin Exp Immunol 136 (2004), 559-567. (Pubitemid 38703693)
34. A. Lleo, C. Selmi, P. Invernizzi, M. Podda, R.L. Coppel, I.R. Mackay, G.J. Gores, A.A. Ansari, J. Van de Water and M.E. Gershwin, Apotopes and the biliary specificity of primary biliary cirrhosis, Hepatology 49 (2009), 871-879.
35. A. Lleo, C.L. Bowlus, G.X. Yang, P. Invernizzi, M. Podda, J. Van de Water, A.A. Ansari, R.L. Coppel, H.J. Worman, G.J. Gores and M.E. Gershwin. Biliary apotopes and antimitochondrial antibodies activate innate immune responses in primary biliary cirrhosis, Hepatology (2010).
36. J.Neuberger, Liver transplantation for primary biliary cirrhosis: Indications and risk of recurrence, J Hepatol 39 (2003), 142-148. (Pubitemid 36920547)
37. D.A. Jacob, U.P. Neumann, M. Bahra, J.M. Langrehr and P. Neuhaus, Liver transplantation for primary biliary cirrhosis: Influence of primary immunosuppression on survival, Transplant Proc 37 (2005), 1691-1692. (Pubitemid 40790797)
38. S. Cha, P.S. Leung, M.E. Gershwin, M.P. Fletcher, A.A. Ansari and R.L. Coppel, Combinatorial autoantibodies to dihydrolipoamide acetyltransferase, themajor autoantigen of primary biliary cirrhosis, ProcNatl Acad Sci U S A 90 (1993), 2527-2531. (Pubitemid 23078661)
39. Y. Ichiki, S. Shimoda, H. Hara, H. Shigematsu, M. Nakamura, K. Hayashida, H. Ishibashi and Y. Niho, Analysis of tcell receptor beta of the tcell clones reactive to the human pdce2 163176 peptide in the context of hladr53 in patients with primary biliary cirrhosis, Hepatology 26 (1997), 728-733. (Pubitemid 27392365)
40. H. Shigematsu, S. Shimoda, M. Nakamura, S.Matsushita, Y. Nishimura, N. Sakamoto, Y. Ichiki, Y. Niho, M.E. Gershwin and H. Ishibashi, Fine specificity of t cells reactive to human pdce2 163176 peptide, the immunodominant autoantigen in primary biliary cirrhosis: Implications for molecular mimicry and crossrecognition among mitochondrial autoantigens, Hepatology 32 (2000), 901-909.
41. Q.Y. Chen, M.J. Rowley and I.R.Mackay, Antiidiotypic antibodies to antipdce2 in primary biliary cirrhosis and normal subjects, Hepatology 29 (1999), 624-631. (Pubitemid 29109571)
42. S. Shimoda, K. Harada, H. Niiro, T. Yoshizumi, Y. Soejima, A. Taketomi, Y. Maehara, K. Tsuneyama, M. Nakamura, A. Komori, K.Migita, Y. Nakanuma, H. Ishibashi, C. Selmi and M.E. Gershwin. Biliary epithelial cells and primary biliary cirrhosis: The role of liverinfiltrating mononuclear cells, Hepatology 47 (2008), 958-965. (Pubitemid 351449687)
43. A.T. Borchers, S. Shimoda, C. Bowlus, C.L. Keen and M.E. Gershwin, Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis, Semin Immunopathol 31 (2009), 309-322.
44. S. Shimoda, H. Miyakawa, M. Nakamura, H. Ishibashi, K. Kikuchi, H. Kita, H. Niiro, Y. Arinobu, N. Ono, I.R.Mackay, M.E.Gershwin andK.Akashi, Cd4 tcell autoreactivity to the mitochondrial autoantigen pdce2 in amanegative primary biliary cirrhosis, J Autoimmun 31 (2008), 110-115.
45. P. Invernizzi and M.E. Gershwin, The genetics of human autoimmune disease, J Autoimmun 33 (2009), 290-299.
46. J.A. Odin, R.C. Huebert, L. CasciolaRosen, N.F. LaRusso and A. Rosen, Bcl2dependent oxidation of pyruvate dehydrogenasee2, a primary biliary cirrhosis autoantigen, during apoptosis, J Clin Invest 108 (2001), 223-232. (Pubitemid 32656246)
47. T.K. Mao, P.A. Davis, J.A. Odin, R.L. Coppel and M.E. Gershwin, Sidechain biology and the immunogenicity of pdce2, the major autoantigen of primary biliary cirrhosis, Hepatology 40 (2004), 1241-1248. (Pubitemid 39656995)
48. S. Matsumura, J. Van De Water, P. Leung, J.A. Odin, K. Yamamoto, G.J. Gores, K. Mostov, A.A. Ansari, R.L. Coppel, Y. Shiratori and M.E. Gershwin, Caspase induction by iga antimitochondrial antibody: Igamediated biliary injury in primary biliary cirrhosis, Hepatology 39 (2004), 1415-1422. (Pubitemid 38569064)
49. E.M. Jacobson, A. Huber and Y. Tomer, The hla gene complex in thyroid autoimmunity: From epidemiology to etiology, J Autoimmun 30 (2008), 58-62.
50. G.S. Cooper, M.L. Bynum and E.C. Somers, Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases, J Autoimmun (2009).
51. M. Sasaki, H. Ikeda and Y. Nakanuma, Activation of atm signaling pathway is involved in oxidative stressinduced expression of mitoinhibitory p21waf1/cip1 in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis: An immunohistochemical study, J Autoimmun 31 (2008), 73-78.
52. J. Allina, B. Hu, D.M. Sullivan, M.I. Fiel, S.N. Thung, S.F. Bronk, R.C. Huebert, J. van de Water, N.F. LaRusso, M.E. Gershwin, G.J. Gores and J.A. Odin. T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis, J Autoimmun 27 (2006), 232-241. (Pubitemid 46199127)
53. H. Nishimoto, G. Yamada, M. Mizuno and T. Tsuji, Immunoelectron microscopic localization of mhc class 1 and 2 antigens on bile duct epithelial cells in patients with primary biliary cirrhosis, Acta Med Okayama 48 (1994), 317-322.
54. J.B. Nelson, S.P. O-Hara, A.J. Small, P.S. Tietz, A.K. Choudhury, R.E. Pagano, X.M. Chen and N.F. LaRusso, Cryptosporidium parvum infects human cholangiocytes via sphingolipidenrichedmembranemicrodomains, CellMicrobiol 8 (2006), 1932-1945. (Pubitemid 44687333)
55. S. AbuMouch, C. Selmi, G.D. Benson, T.P. Kenny, P. Invernizzi, M. Zuin, M. Podda, L. Rossaro and M.E. Gershwin, Geographic clusters of primary biliary cirrhosis, Clin Dev Immunol 10 (2003), 127-131. (Pubitemid 38089403)
56. C. Selmi, P. Invernizzi, M. Zuin, M. Podda and M.E. Gershwin, Genetics and geoepidemiology of primary biliary cirrhosis: Following the footprints to disease etiology, Semin Liver Dis 25 (2005), 265-280. (Pubitemid 41254575)
57. S.Arber, J.McKinlay, A.Adams, L.Marceau, C. Link andA. O-Donnell, Patient characteristics and inequalities in doctors- diagnostic and management strategies relating to chd: A videosimulation experiment, Soc Sci Med 62 (2006), 103-115. (Pubitemid 41728108)
58. R.G. Watson, P.W. Angus, M. Dewar, B. Goss, R.B. Sewell and R.A. Smallwood, Low prevalence of primary biliary cirrhosis in victoria, australia. Melbourne liver group, Gut 36 (1995), 927-930.
59. S. Sood, P.J. Gow, J.M. Christie and P.W. Angus, Epidemiology of primary biliary cirrhosis in victoria, australia: High prevalence in migrant populations, Gastroenterology 127 (2004), 470-475. (Pubitemid 39091895)
60. W.R. Kim, K.D. Lindor, G.R. Locke, 3rd, T.M. Therneau, H.A. Homburger, K.P. Batts, B.P. Yawn, J.L. Petz, L.J. Melton, 3rd and E.R. Dickson, Epidemiology and natural history of primary biliary cirrhosis in a us community, Gastroenterology 119 (2000), 1631-1636. (Pubitemid 32198688)
61. L. Arbour, R. Rupps, L. Field, P. Ross, A. Erikson, H. Henderson, W. Hill and E. Yoshida, Characteristics of primary biliary cirrhosis in british columbia-s first nations population, Can J Gastroenterol 19 (2005), 305-310. (Pubitemid 40812615)
62. A. Ala, C.M. Stanca, M. BuGhanim, I. Ahmado, A.D. Branch, T.D. Schiano, J.A. Odin and N. Bach, Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites, Hepatology (Baltimore, Md 43 (2006), 525-531.
63. P. Invernizzi, C. Selmi, F. Poli, S. Frison, A. Floreani, D. Alvaro, P. Almasio, F. Rosina, M. Marzioni, L. Fabris, L. Muratori, L. Qi, M.F. Seldin, M.E. Gershwin and M. Podda, Human leukocyte antigen polymorphisms in italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controls, Hepatology (Baltimore, Md 48 (2008), 1906-1912.
64. P. Invernizzi andM.E. Gershwin, The genetic basis of primary biliary cirrhosis: Premises, not promises, Gastroenterology 135 (2008), 1044-1047.
65. M.E. Gershwin, C. Selmi, H.J.Worman, E.B. Gold, M.Watnik, J. Utts, K.D. Lindor, M.M. Kaplan and J.M. Vierling, Risk factors and comorbidities in primary biliary cirrhosis: A controlled interviewbased study of 1032 patients, Hepatology 42 (2005), 1194-1202. (Pubitemid 43112687)
66. A. ParikhPatel, E.B. Gold, H. Worman, K.E. Krivy and M.E. Gershwin. Risk factors for primary biliary cirrhosis in a cohort of patients from the united states, Hepatology 33 (2001), 16-21. (Pubitemid 32016882)
67. M.I. Prince, S.J.Ducker andO.F. James, Casecontrol studies of risk factors for primary biliary cirrhosis in two united kingdom populations, Gut 59 (2010), 508-512.
68. M.P. Leon, J.A. Kirby, P. Gibbs, A.D. Burt and M.F. Bassendine, Immunogenicity of biliary epithelial cells: Study of the expression of b7molecules, JHepatol 22 (1995), 591-595.
69. C. Selmi, Theworldwide gradient of autoimmune conditions, Autoimmun Rev 9 (2010), A247-A250.
70. M.F. Fraga, E. Ballestar, M.F. Paz, S. Ropero, F. Setien, M.L. Ballestar, D. HeineSuner, J.C. Cigudosa, M. Urioste, J. Benitez, M. BoixChornet, A. SanchezAguilera, C. Ling, E. Carlsson, P. Poulsen, A. Vaag, Z. Stephan, T.D. Spector, Y.Z. Wu, C. Plass and M. Esteller, Epigenetic differences arise during the lifetime of monozygotic twins, Proc Natl Acad Sci U S A 102 (2005), 10604-10609. (Pubitemid 41061601)
71. Q. Lu, Y. Renaudineau, S. Cha, G. Ilei, W.H. Brooks, C. Selmi, A. Tzioufas, J.O. Pers, S. Bombardieri, M.E. Gershwin, S. Gay and P. Youinou, Epigenetics in autoimmune disorders: Highlights of the 10th sjogren-s syndrome symposium, Autoimmun Rev (2010).
72. M. Dittmar, C. Bischofs, N. Matheis, R. Poppe and G.J. Kahaly, A novel mutation in the dnase1 gene is related with protein instability and decreased enzyme activity in thyroid autoimmunity, J Autoimmun 32 (2009), 7-13.
73. K.M. Pauley, S. Cha and E.K. Chan, Microrna in autoimmunity and autoimmune diseases, J Autoimmun 32 (2009), 189-194.
74. J. Van de Water, M.E. Gershwin, P. Leung, A. Ansari and R.L. Coppel, The autoepitope of the 74kd mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase, J Exp Med 167 (1988), 1791-1799.
75. H. Kita, S. Matsumura, X.S. He, A.A. Ansari, Z.X. Lian, J. Van de Water, R.L. Coppel, M.M. Kaplan and M.E. Gershwin, Quantitative and functional analysis of pdce2specific autoreactive cytotoxic t lymphocytes in primary biliary cirrhosis, J Clin Invest 109 (2002), 1231-1240. (Pubitemid 34496601)
76. S. Matsumura, H. Kita, X.S. He, A.A. Ansari, Z.X. Lian, J. Van De Water, K. Yamamoto, T. Tsuji, R.L. Coppel, M. Kaplan and M.E. Gershwin, Comprehensive mapping of hlaa0201restricted cd8 tcell epitopes on pdce2 in primary biliary cirrhosis, Hepatology 36 (2002), 1125-1134. (Pubitemid 35253428)
77. S. Braun, C. Berg, S. Buck, M. Gregor and R. Klein, Catalytic domain of pdce2 contains epitopes recognized by antimitochondrial antibodies in primary biliary cirrhosis, World J Gastroenterol 16 (2010), 973-981.
78. S. Shimoda, M. Nakamura, H. Ishibashi, A. Kawano, T. Kamihira, N. Sakamoto, S.Matsushita, A. Tanaka, H.J.Worman, M.E. Gershwin and M. Harada, Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis, Gastroenterology 124 (2003), 1915-1925. (Pubitemid 36666786)
79. E. Karnabi, Y. Qu, R. Wadgaonkar, S. Mancarella, Y. Yue, M. Chahine, R.M. Clancy, J.P. Buyon and M. Boutjdir, Congenital heart block: Identification of autoantibody binding site on the extracellular loop (domain i, s5-s6) of alpha(1d) ltype ca channel, J Autoimmun 34 (2010), 80-86.
80. S.F.Bruggraber, P.S. Leung, K.Amano, C.Quan,M.J.Kurth, M.H. Nantz, G.D. Benson, J. Van de Water, V. Luketic, T.E. Roche, A.A. Ansari, R.L. Coppel and M.E. Gershwin, Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis, Gastroenterology 125 (2003), 1705-1713. (Pubitemid 37500435)
81. D.P. Bogdanos and D. Vergani, Bacteria and primary biliary cirrhosis, Clin Rev Allergy Immunol 36 (2009), 30-39.
82. M.I. Prince, A. Chetwynd, P. Diggle, M. Jarner, J.V. Metcalf and O.F. James, The geographical distribution of primary biliary cirrhosis in a welldefined cohort, Hepatology 34 (2001), 1083-1088. (Pubitemid 33096579)
83. A.C. Anand, E. Elias and J.M. Neuberger, Endstage primary biliary cirrhosis in a first generation migrant south asian population, Eur J Gastroenterol Hepatol 8 (1996), 663-666. (Pubitemid 26241595)
84. I. Haruta, E. Hashimoto, Y. Kato, K. Kikuchi, H. Kato, J. Yagi, T. Uchiyama, M. Kobayash and K. Shiratori, Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis, Autoimmunity 39 (2006), 129-135. (Pubitemid 43675256)
85. D.E. Jones, J.M. Palmer, A.D.Burt, C.Walker, A.J. Robe and J.A.Kirby. Bacterial motif DNA as an adjuvant for the breakdown of immune selftolerance to pyruvate dehydrogenase complex, Hepatology 36 (2002), 679-686. (Pubitemid 34977179)
86. R.Y. Lan, T.L. Salunga, K. Tsuneyama, Z.X. Lian, G.X. Yang,W. Hsu, Y.Moritoki, A.A. Ansari, C. Kemper, J. Price, J.P.Atkinson, R.L. Coppel andM.E. Gershwin, Hepatic il17 responses in human and murine primary biliary cirrhosis, J Autoimmun 32 (2009), 43-51.
87. G. Rong, Y. Zhou, Y. Xiong, L. Zhou, H. Geng, T. Jiang, Y. Zhu, H. Lu, S. Zhang, P. Wang, B. Zhang and R. Zhong, Imbalance between t helper type 17 and t regulatory cells in patients with primary biliary cirrhosis: The serum cytokine profile and peripheral cell population, Clin Exp Immunol 156 (2009), 217-225.
88. K. Harada, S. Shimoda, Y. Sato, K. Isse, H. Ikeda and Y. Nakanuma, Periductal interleukin17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis, Clin Exp Immunol 157 (2009), 261-270.
89. J. Van de Water, H. Ishibashi, R.L. Coppel and M.E. Gershwin, Molecular mimicry and primary biliary cirrhosis: Premises not promises, Hepatology 33 (2001), 771-775. (Pubitemid 32246623)
90. N. AgmonLevin, B.S. Katz and Y. Shoenfeld, Infection and primary biliary cirrhosis, Isr Med Assoc J 11 (2009), 112-115.
91. T.K. Mao, Z.X. Lian, C. Selmi, Y. Ichiki, P. Ashwood, A.A. Ansari, R.L. Coppel, S. Shimoda, H. Ishibashi and M.E. Gershwin, Altered monocyte responses to defined tlr ligands in patients with primary biliary cirrhosis, Hepatology 42 (2005), 802-808. (Pubitemid 41401117)
92. O. Barzilai, M. Ram and Y. Shoenfeld, Viral infection can induce the production of autoantibodies, Curr Opin Rheumatol 19 (2007), 636-643. (Pubitemid 47530886)
93. M.L. SantiagoRaber, I. DunandSauthier, T. Wu, Q.Z. Li, S. Uematsu, S. Akira, W. Reith, C. Mohan, B.L. Kotzin and S. Izui, Critical role of tlr7 in the acceleration of systemic lupus erythematosus in tlr9deficient mice, J Autoimmun 34 (2010), 339-348.
94. J.D. Fraser and T. Proft, The bacterial superantigen and superantigenlike proteins, Immunol Rev 225 (2008), 226-243.
95. J. Czarneski, J.C. Rassa and S.R. Ross, Mouse mammary tumor virus and the immune system, Immunol Res 27 (2003), 469-480.
96. R. Kuppers, B cells under influence: Transformation of b cells by epsteinbarr virus, Nat Rev Immunol 3 (2003), 801-812. (Pubitemid 37328658)
97. F.L. van de Veerdonk, M.S. Gresnigt, B.J. Kullberg, J.W. van der Meer, L.A. Joosten and M.G. Netea, Th17 responses and host defense against microorganisms: An overview, BMB Rep 42 (2009), 776-787.
98. R.Y. Lan, C. Cheng, Z.X. Lian, K. Tsuneyama, G.X.Yang, Y. Moritoki, Y.H. Chuang, T. Nakamura, S. Saito, S. Shimoda, A. Tanaka, C.L. Bowlus, Y. Takano, A.A. Ansari, R.L. Coppel and M.E. Gershwin, Livertargeted and peripheral blood alterations of regulatory t cells in primary biliary cirrhosis, Hepatology 43 (2006), 729-737.
99. G.P. Morris, N.K. Brown and Y.C. Kong, Naturallyexisting cd4(+)cd25(+)foxp3(+) regulatory t cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen, J Autoimmun 33 (2009), 68-76.
100. R.E. Nickowitz and H.J. Worman, Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein gp210, J Exp Med 178 (1993), 2237-2242. (Pubitemid 23344884)
101. I. Mayo, P. Arizti, A. Pares, J. Oliva, R.A. Doforno, M.R. de Sagarra, J. Rodes and J.G. Castano, Antibodies against the coohterminal region of e. Coli clpp protease in patients with primary biliary cirrhosis, J Hepatol 33 (2000), 528-536.
102. H. Baum, D.P. Bogdanos and D. Vergani, Antibodies to clp protease in primary biliary cirrhosis: Possible role of a mimicking tcell epitope, J Hepatol 34 (2001), 785-787. (Pubitemid 32488803)
103. D.P. Bogdanos, H. Baum, U.C. Sharma, A. Grasso, Y. Ma, A.K. Burroughs and D. Vergani, Antibodies against homologous microbial caseinolytic proteases p characterise primary biliary cirrhosis, J Hepatol 36 (2002), 14-21. (Pubitemid 34234011)
104. C. Selmi, D.L.Balkwill, P. Invernizzi, A.A.Ansari, R.L.Coppel, M. Podda, P.S. Leung, T.P.Kenny, J.VanDeWater,M.H. Nantz, M.J. Kurth and M.E. Gershwin, Patients with primary biliary cirrhosis react against a ubiquitous xenobioticmetabolizing bacterium, Hepatology 38 (2003), 1250-1257. (Pubitemid 37314834)
105. M.M. Kaplan, Novosphingobium aromaticivorans: A potential initiator of primary biliary cirrhosis, Am J Gastroenterol 99 (2004), 2147-2149. (Pubitemid 39524705)
106. R. Stemerowicz, U. Hopf, B. Moller, C. Wittenbrink, A. Rodloff, R. Reinhardt, M. Freudenberg and C. Galanos, Are antimitochondrial antibodies in primary biliary cirrhosis induced by r(rough)mutants of enterobacteriaceae? Lancet 2 (1988), 1166-1170. (Pubitemid 18267006)
107. H. Kita, S. Matsumura, X.S. He, A.A. Ansari, Z.X. Lian, J. Van de Water, R.L. Coppel, M.M. Kaplan and M.E. Gershwin, Analysis of tcr antagonism andmolecular mimicry of an hlaa0201restricted ctl epitope in primary biliary cirrhosis, Hepatology 36 (2002), 918-926.
108. I. Haruta, K. Kikuchi, E. Hashimoto, H. Kato, K. Hirota, M. Kobayashi, Y.Miyake, T.Uchiyama, J.Yagi andK. Shiratori, A possible role of histonelike DNAbinding protein of streptococcus intermedius in the pathogenesis of bile duct damage in primary biliary cirrhosis, Clin Immunol 127 (2008), 245-251.
109. D.P. Bogdanos, H. Baum, M. Okamoto, P. Montalto, U.C. Sharma, E.I. Rigopoulou, J. Vlachogiannakos, Y. Ma, A.K. Burroughs and D. Vergani, Primary biliary cirrhosis is characterized by igg3 antibodies crossreactive with the major mitochondrial autoepitope and its lactobacillus mimic, Hepatology 42 (2005), 458-465. (Pubitemid 41061099)
110. T.J. Sayers and H. Baum, Possible crossreactivity of human antimitochondrial antibodies with membrane vesicles of paracoccus denitrificans, Biochem Soc Trans 4 (1976), 138-139.
111. G. Jan, M. Le Henaff, C. Fontenelle and H. Wroblewski, Biochemical and antigenic characterisation of mycoplasma gallisepticum membrane proteins p52 and p67 (pmga), Arch Microbiol 177 (2001), 81-90. (Pubitemid 34031238)
112. C.P. Berg, T.R. Kannan, R. Klein, M. Gregor, J.B. Baseman, S.Wesselborg, K. Lauber and G.M. Stein, Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis, Liver Int 29 (2009), 797-809.
113. D.P. Bogdanos, A. Pares, H. Baum, L. Caballeria, E.I. Rigopoulou, Y. Ma, A.K. Burroughs, J. Rodes and D. Vergani, Diseasespecific crossreactivity between mimicking peptides of heat shock protein of mycobacterium gordonae and dominant epitope of e2 subunit of pyruvate dehydrogenase is common in spanish but not british patients with primary biliary cirrhosis, J Autoimmun 22 (2004), 353-362. (Pubitemid 38543228)
114. D.P. Bogdanos, A. Koutsoumpas, H. Baum and D. Vergani, Borrelia burgdorferi: A new selfmimicking trigger in primary biliary cirrhosis, Dig Liver Dis 38 (2006), 781-782; author reply 782-783.
115. P.N. Uzoegwu, H. Baum and J. Williamson, The occurrence and localization in trypanosomes and other endoparasites of an antigen crossreacting with mitochondrial antibodies of primary biliary cirrhosis, Comp Biochem Physiol B 88 (1987), 1181-1189.
116. K. Harada, K. Tsuneyama, Y. Sudo, S. Masuda and Y. Nakanuma, Molecular identification of bacterial 16s ribosomal rna gene in liver tissue of primary biliary cirrhosis: Is propionibacterium acnes involved in granuloma formation? Hepatology 33 (2001), 530-536. (Pubitemid 32185213)
117. S.A. Morshed, M. Nishioka, I. Saito, K. Komiyama and I. Moro, Increased expression of epsteinbarr virus in primary biliary cirrhosis patients, Gastroenterol Jpn 27 (1992), 751-758. (Pubitemid 23066541)
118. J. Mattner, P.B. Savage, P. Leung, S.S. Oertelt, V. Wang, O. Trivedi, S.T. Scanlon, K. Pendem, L. Teyton, J. Hart, W.M. Ridgway, L.S.Wicker, M.E.Gershwin and A. Bendelac, Liver autoimmunity triggered by microbial activation of natural killer t cells, Cell Host Microbe 3 (2008), 304-315. (Pubitemid 351637431)
119. M.J. Goo, M.R. Ki, H.R. Lee, I.H. Hong, J.K. Park, H.J. Yang, D.W. Yuan, O.K. Hwang, S.H. Do, S.E. Yoo and K.S. Jeong, Primary biliary cirrhosis, similar to that in human beings, in a male c57bl/6 mouse infected with helicobacter pylori, Eur J Gastroenterol Hepatol 20 (2008), 1045-1048.
120. G.J. Tobon, P. Youinou and A. Saraux, The environment, geoepidemiology, and autoimmune disease: Rheumatoid arthritis, J Autoimmun 35 (2010), 10-14.
121. C.L. Burek and M.V. Talor, Environmental triggers of autoimmune thyroiditis, J Autoimmun 33 (2009), 183-189.
122. U. Christen, P. Jeno and J. Gut, Halothane metabolism: The dihydrolipoamide acetyltransferase subunit of the pyruvate dehydrogenase complex molecularly mimics trifluoroacetylprotein adducts, Biochemistry 32 (1993), 1492-1499. (Pubitemid 23077556)
123. H.R. Walden, J.A. Kirby, S.J. Yeaman, J. Gray, D.E. Jones and J.M. Palmer, Xenobiotic incorporation into pyruvate dehydrogenase complex can occur via the exogenous lipoylation pathway, Hepatology 48 (2008), 1874-1884.
124. R. Rieger, P.S. Leung, M.R. Jeddeloh, M.J. Kurth, M.H. Nantz, K.S. Lam, D. Barsky, A.A. Ansari, R.L. Coppel, I.R. Mackay and M.E. Gershwin, Identification of 2nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis, J Autoimmun 27 (2006), 7-16. (Pubitemid 44279362)
125. P.S. Leung, O. Park, K. Tsuneyama, M.J. Kurth, K.S. Lam, A.A. Ansari, R.L. Coppel and M.E. Gershwin, Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization, J Immunol 179 (2007), 2651-2657.
126. K. Wakabayashi, K. Yoshida, P.S. Leung, Y. Moritoki, G.X. Yang, K. Tsuneyama, Z.X. Lian, T. Hibi, A.A. Ansari, L.S. Wicker, W.M. Ridgway, R.L. Coppel, I.R. Mackay and M.E. Gershwin, Induction of autoimmune cholangitis in nonobese diabetic (nod).1101 mice following a chemical xenobiotic immunization, Clin Exp Immunol 155 (2009), 577-586.
127. K. Wakabayashi, Z.X. Lian, P.S. Leung, Y. Moritoki, K. Tsuneyama,M.J.Kurth,K.S. Lam,K.Yoshida, G.X.Yang, T. Hibi, A.A.Ansari,W.M. Ridgway, R.L. Coppel, I.R.Mackay and M.E. Gershwin, Loss of tolerance in c57bl/6 mice to the autoantigen e2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease, Hepatology (Baltimore, Md 48 (2008), 531-540.
128. S.A. Long, C. Quan, J. Van de Water, M.H. Nantz, M.J. Kurth, D. Barsky, M.E. Colvin, K.S. Lam, R.L. Coppel, A. Ansari and M.E. Gershwin, Immunoreactivity of organic mimeotopes of the e2 component of pyruvate dehydrogenase: Connecting xenobiotics with primary biliary cirrhosis, J Immunol 167 (2001), 2956-2963. (Pubitemid 32768932)
129. P.S. Leung, C. Quan, O. Park, J. Van de Water, M.J. Kurth, M.H. Nantz, A.A. Ansari, R.L. Coppel, K.S. Lam and M.E. Gershwin, Immunization with a xenobiotic 6bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies, J Immunol 170 (2003), 5326-5332. (Pubitemid 36554768)
130. K. Amano, P.S. Leung, Q. Xu, J.Marik, C. Quan,M.J.Kurth, M.H. Nantz, A.A. Ansari, K.S. Lam,M. Zeniya, R.L. Coppel and M.E. Gershwin, Xenobioticinduced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible, J Immunol 172 (2004), 6444-6452. (Pubitemid 38621254)
131. A. Lleo, P.M. Battezzati, C. Selmi, M.E. Gershwin and M. Podda, Is autoimmunity a matter of sex? Autoimmun Rev 7 (2008), 626-630.
132. A. ParikhPatel, E. Gold, J. Utts and M.E. Gershwin, The association between gravidity and primary biliary cirrhosis, Ann Epidemiol 12 (2002), 264-272. (Pubitemid 34428626)
133. D. Bogdanos, T. Pusl, C. Rust, D. Vergani and U. Beuers, Primary biliary cirrhosis following lactobacillus vaccination for recurrent vaginitis, J Hepatol 49 (2008), 466-473.
134. P. Invernizzi, M. Miozzo, P.M. Battezzati, I. Bianchi, F.R. Grati, G. Simoni, C. Selmi, M. Watnik, M.E. Gershwin and M. Podda, Frequency ofmonosomy x inwomenwith primary biliary cirrhosis, Lancet 363 (2004), 533-535. (Pubitemid 38229455)
135. C. Selmi, The x in sex: How autoimmune diseases revolve around sex chromosomes, Best Pract Res Clin Rheumatol 22 (2008), 913-922.
136. Y. Svyryd, G.H. Molina, F. Vargas, J. SanchezGuerrero, D.A. Segovia and O.M. Mutchinick, X chromosome monosomy in primary and overlapping autoimmune diseases, Autoimmun Rev (2010).
137. P. Invernizzi, S. Pasini, C. Selmi, M.E. Gershwin and M. Podda, Female predominance and x chromosome defects in autoimmune diseases, J Autoimmun 33 (2009), 12-16.
138. L. Persani, R. Rossetti, C. Cacciatore and M. Bonomi, Primary ovarian insufficiency: X chromosome defects and autoimmunity, J Autoimmun 33 (2009), 35-41.
139. A.H. Sawalha, J.B. Harley and R.H. Scofield, Autoimmunity and klinefelter-s syndrome: When men have two x chromosomes, J Autoimmun 33 (2009), 31-34.
140. Y. Shapira, N. AgmonLevin and Y. Shoenfeld, Defining and analyzing geoepidemiology and human autoimmunity, J Autoimmun 34 (2010), J168-J177.
141. Y. Shoenfeld, C. Selmi, E. Zimlichman and M.E. Gershwin, The
142. G.S. Cooper, M.L. Bynum and E.C. Somers, Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases, J Autoimmun 33 (2009), 197-207
143. P. Invernizzi, Geoepidemiology of autoimmune liver diseases, J Autoimmun 34 (2010), J300-J306.
144. V. Chandran and S.P. Raychaudhuri, Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis, J Autoimmun 34 (2010), J314-J321.
145. P.Youinou, J.O. Pers,M.E.Gershwin andY. Shoenfeld, Geoepidemiology and autoimmunity, J Autoimmun 34 (2010), J163-J167.
146. I. Sekigawa, M. Kawasaki, H. Ogasawara, K. Kaneda, H. Kaneko, Y. Takasaki and H. Ogawa, DNA methylation: Its contribution to systemic lupus erythematosus, Clin Exp Med 6 (2006), 99-106. (Pubitemid 44630739)
147. P.S. Patole, R.D. Pawar, J. Lichtnekert, M. Lech, O.P. Kulkarni, A. Ramanjaneyulu, S. Segerer and H.J. Anders, Coactivation of tolllike receptor3 and 7 in immune complex glomerulonephritis, J Autoimmun 29 (2007), 52-59. (Pubitemid 47016916)
148. J.T. Salas, J.M. Banales, S. Sarvide, S. Recalde, A. Ferrer, I. Uriarte, R.P. Oude Elferink, J. Prieto and J.F. Medina, Ae2a,bdeficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis, Gastroenterology 134 (2008), 1482-1493. (Pubitemid 351626951)
149. J.M. Palmer, A.J.Robe, A.D.Burt, J.A.Kirby andD.E. Jones, Covalent modification as a mechanism for the breakdown of immune tolerance to pyruvate dehydrogenase complex in the mouse, Hepatology (Baltimore, Md 39 (2004), 1583-1592. (Pubitemid 38702659)
150. Y. Ueno, Y. Moritoki, T. Shimosegawa and M.E. Gershwin, Primary biliary cirrhosis: Whatwe knowandwhatwewant to know about human pbc and spontaneous pbc mouse models, J Gastroenterol 42 (2007), 189-195. (Pubitemid 46488227)
151. K.A. Padgett, R.Y. Lan, P.C. Leung, A. Lleo, K. Dawson, J. Pfeiff, T.K. Mao, R.L. Coppel, A.A. Ansari and M.E. Gershwin, Primary biliary cirrhosis is associated with altered hepatic microrna expression, J Autoimmun 32 (2009), 246-253.
152. L. Senolt, J. Vencovsky, K. Pavelka, C. Ospelt and S. Gay, Prospective new biological therapies for rheumatoid arthritis, Autoimmun Rev 9 (2009), 102-107.
153. N.R. York, J.P. Mendoza, S.B. Ortega, A. Benagh, A.F. Tyler, M. Firan and N.J. Karandikar, Immune regulatory cnsreactive cd8+t cells in experimental autoimmune encephalomyelitis, J Autoimmun 35 (2010), 33-44.
154. P.S. Leung, A. Dhirapong, P.Y.Wu andM.H. Tao, Gene therapy in autoimmune diseases: Challenges and opportunities, Autoimmun Rev 9 (2010), 170-174.
155. D.P.Bogdanos, H.Baum, F.Gunsar, D.Arioli, D. Polymeros, Y.Ma, A.K. Burroughs and D. Vergani, Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and helicobacter pylori does not lead to immunological crossreactivity, Scand J Gastroenterol 39 (2004), 981-987. (Pubitemid 39388463)
156. P.S. Leung,O. Park, S.Matsumura, A.A.Ansari, R.L. Coppel and M.E. Gershwin, Is there a relation between Chlamydia infection and primary biliary cirrhosis? Clin Dev Immunol 10 (2003), 227-233. (Pubitemid 38089415)
157. J. O-Donohue, B. McFarlane, A. Bomford, M. Yates and R.Williams, Antibodies to atypical mycobacteria in primary biliary cirrhosis, J Hepatol 21 (1994), 887-889. (Pubitemid 24374160)
158. W. Sakly,M. Jeddi and I. Ghedira, Antisaccharomyces cerevisiae antibodies in primary biliary cirrhosis, Dig Dis Sci 53 (2008), 1983-1987.
159. L. Xu, Z. Shen, L. Guo, B. Fodera, A. Keogh, R. Joplin, B. O-Donnell, J. Aitken, W. Carman, J. Neuberger and A. Mason, Does a betaretrovirus infection trigger primary biliary cirrhosis? Proc Natl Acad Sci U S A 100 (2003), 8454-8459. (Pubitemid 36842566)
160. C. Selmi, S.R. Ross, A.A. Ansari, P. Invernizzi, M. Podda, R.L. Coppel and M.E. Gershwin, Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis, Gastroenterology 127 (2004), 493-501. (Pubitemid 39091898)